BioSpace News Archive

Debbie Demchak, former executive at JP Morgan, and Scott Izzo, the former director and current senior consultant for the Richard King Mellon Foundation, have been named to its board of directors effective immediately.

Acquisition allows KD Pharma to further expand its leading position in the omega-3 pharmaceutical market

Synaptive Medical Inc., a leader in surgical planning and navigation technology, announced today that Cameron Piron, President and Chief Strategy Officer, will present an overview of the Company and its business strategy during the Jefferies 2019 Healthcare Conference taking place June 4-7, 2019 in New York City.

Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the re-launch of Zenatane® (Isotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg, a therapeutic equivalent generic version of Accutane®, approved by the U.S. Food and Drug Administration (USFDA)

Aadi Bioscience, Inc (Aadi), a privately held clinical stage biopharmaceutical company, today released preliminary data on the ongoing nab-sirolimus (ABI-009) registration trial (AMPECT) for Advanced (metastatic or locally advanced) Malignant PEComa (perivascular epithelioid cell tumor) - a rare form of sarcoma for which there is no currently approved therapy.

Building from the company’s best-selling SCIEX Triple Quad™ for over 10 years, users can now get triple quad sensitivity plus QTRAP® functionality in one system

SCIEX, a global leader in life science analytical technologies, introduces Acoustic Ejection Mass Spectrometry (AEMS) technology, a milestone for the future of high-throughput quantification, at ASMS 2019. AEMS technology, incorporating the Open Port Interface (OPI) and Acoustic Droplet Ejection (ADE), has received unprecedented enthusiasm from collaborators, leading SCIEX to introduce the technology ahead of commercialization

The U.S. Food and Drug Administration is warning consumers about safety concerns regarding an ingredient called vinpocetine that is found in dietary supplements, specifically concerns about the use of this ingredient by women of childbearing age.

During the 2019 BIO (Biotechnology Innovation Organization) International Convention (BIO 2019), CATALIS Québec announced that its eight pharmaceutical partners have renewed their financial commitments

“I desired to get into shape by toning my muscles,” said an inventor from Oxnard, California. “This inspired me to develop a better piece of exercise equipment that could provide complete toning.”